Recipharm

Recipharm is a leading contract development and manufacturing organisation (CDMO) headquartered in Stockholm, Sweden. We operate development and manufacturing facilities in France, Germany, India, Israel, Italy, Portugal, Spain, Sweden, the UK and the US and are continuing to grow and expand our offering for our customers. Employing over 5,200 people, we are focused on supporting pharmaceutical companies with our full service offering, taking products from early development through to commercial production. For over 25 years, we have partnered with our clients throughout the entire product lifecycle, providing pharmaceutical expertise and managing complexity, time and time again. We conduct our business as we always have and continue to deliver value for money with each customer’s needs firmly at the heart of all that we do.

Type of Drugs Manufactured:

Small Molecule;Biologics;Cell & Gene Therapy

CDMO Services:

Drug Substance Manufacturing (API);Drug Product Formulation (FDF);Research & Development;Packaging;Regulatory Services;Analytical Development

No. of Manufacturing Facilities:

More than 10

High Potent Products capabilities:

OEB 4-5

Facilities Locations:

Europe;Middle East;North America;South Asia

Regulatory Approvals for facilities:

FDA (United States);EMA (Europe);ISO;GMP;PMDA (Japan);NMPA (China);Health Canada;ANVISA (Brazil)

Manufacturing Technologies:

Blow-Fill-Seal (BFS);Cartridges;Liquids;Lyophilized amps/vials;Pre-Filled Syringes (PFS);Semi-solids;Solids;Sterile Ampoules;Sterile Vials